Towards the development of human immune-system-on-a-chip platforms

Citations of this article
Mendeley users who have this article in their library.


Organ-on-a-chip (OoCs) platforms could revolutionize drug discovery and might ultimately become essential tools for precision therapy. Although many single-organ and interconnected systems have been described, the immune system has been comparatively neglected, despite its pervasive role in the body and the trend towards newer therapeutic products (i.e., complex biologics, nanoparticles, immune checkpoint inhibitors, and engineered T cells) that often cause, or are based on, immune reactions. In this review, we recapitulate some distinctive features of the immune system before reviewing microfluidic devices that mimic lymphoid organs or other organs and/or tissues with an integrated immune system component.




Polini, A., del Mercato, L. L., Barra, A., Zhang, Y. S., Calabi, F., & Gigli, G. (2019, February 1). Towards the development of human immune-system-on-a-chip platforms. Drug Discovery Today. Elsevier Ltd.

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free